Quaker Chemical EVP Bijlani to exit Sept. 2026
Quaker Chemical Corporation (KWR) disclosed that, effective September 30, 2026, Jeewat Bijlani will no longer serve as Executive Vice President, Global Specialty and Chief Growth Officer.
Rhea-AI Filing Summary
Quaker Chemical Corporation (KWR) disclosed that, effective September 30, 2026, Jeewat Bijlani will no longer serve as Executive Vice President, Global Specialty and Chief Growth Officer. The company states that his departure is not related to any disagreement with Quaker Houghton.
Mr. Bijlani’s separation will be treated as a termination without cause for purposes of all applicable plan benefits and his employment agreement dated September 28, 2017, effective August 1, 2019. Subject to executing a customary release of claims, he will receive severance payments and benefits consistent with those described in Quaker Chemical’s Proxy Statement filed on March 31, 2026.
Positive
- None.
Negative
- None.
Insights
Analyzing...
8-K Event Classification
2 items: 5.02, 9.01
2 items
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers
Governance
Key personnel changes including departures, elections, or appointments of directors and executive officers.
Item 9.01
Financial Statements and Exhibits
Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Key Figures
Effective departure date: September 30, 2026
Employment agreement date: September 28, 2017
Employment agreement effective date: August 1, 2019
+2 more
5 metrics
Effective departure date
September 30, 2026
Date when Jeewat Bijlani will no longer serve as EVP, Global Specialty and Chief Growth Officer
Employment agreement date
September 28, 2017
Date of Bijlani Employment Agreement governing severance terms
Employment agreement effective date
August 1, 2019
Effective date of Bijlani Employment Agreement
Proxy Statement filing date
March 31, 2026
Proxy Statement describing severance payments and benefits
Form 8-K signature date
September 8, 2026
Date Quaker Chemical executed the report
Key Terms
termination without cause, customary release of claims, Proxy Statement, Inline XBRL
4 terms
termination without cause regulatory
"Mr. Bijlani’s separation from the Company is a termination without cause"
customary release of claims regulatory
"subject to executing a customary release of claims, Mr. Bijlani will be entitled"
Proxy Statement regulatory
"consistent with those described in the Company’s Proxy Statement filed"
A proxy statement is a document companies send to shareholders ahead of a meeting that lays out the items up for a vote—like who will sit on the board, executive pay, and major corporate decisions—and provides background so shareholders can decide how to cast their votes or appoint someone to vote for them. Think of it as an agenda plus a ballot and briefing notes, important because the outcomes can change control, strategy, and value.
Inline XBRL technical
"Cover Page Interactive Data File (embedded within the Inline XBRL document)"
Inline XBRL is a file format for financial filings that embeds machine-readable data tags directly inside the human-readable report, so the same document can be read by people and parsed by software. For investors it makes extracting, comparing and verifying financial numbers faster and more reliable—like a grocery list where each item also has a barcode—reducing manual errors and speeding up analysis.
FAQ
What executive leadership change did QUAKER CHEMICAL CORP (KWR) announce in this Form 8-K?
Quaker Chemical announced that, effective September 30, 2026, Jeewat Bijlani will no longer serve as Executive Vice President, Global Specialty and Chief Growth Officer. The company states his departure is not related to any disagreement between him and the company.
How is Jeewat Bijlani’s separation from QUAKER CHEMICAL CORP (KWR) classified?
The company classifies Jeewat Bijlani’s separation as a termination without cause for purposes of all applicable plan benefits and contractual entitlements under his employment agreement and relevant company plans and programs.
What severance benefits will Jeewat Bijlani receive from QUAKER CHEMICAL CORP (KWR)?
Subject to executing a customary release of claims, Jeewat Bijlani will receive severance payments and benefits under his employment agreement and company plans, consistent with those described in the Proxy Statement filed March 31, 2026. Specific amounts are not detailed here.
Is Jeewat Bijlani’s departure from QUAKER CHEMICAL CORP (KWR) due to a disagreement with the company?
No. Quaker Chemical states that Mr. Bijlani’s departure is not related to any disagreement between him and the company. It is characterized as a termination without cause under applicable agreements and plans.
When did QUAKER CHEMICAL CORP (KWR) sign Jeewat Bijlani’s employment agreement referenced in the 8-K?
The referenced employment agreement for Jeewat Bijlani is dated September 28, 2017 and became effective August 1, 2019. Severance payments and benefits in connection with his separation will be provided under this agreement and applicable company plans.
AI-generated analysis. How Rhea-AI works. Not financial advice.
